SenoRx , Nasdaq: SENO
Produces medical devices for the diagnosis and treatment of breast cancer.
Industry: Health Care
First Day Return: +2.3%
Industry: Health Care
SENO
Produces medical devices for the diagnosis and treatment of breast cancer.
| IPO Data | |
|---|---|
| IPO File Date | 05/25/2006 |
| Offer Price | $8.00 |
| Price Range $11.00 - $13.00 | |
| Offer Shares (mm) | 5.5 |
| Deal Size ($mm) | $44 |
| Lock-Up Date | IPO Pro Only |
| Street Research | IPO Pro Only |
| IPO Data | |
|---|---|
| IPO Date | 03/28/2007 |
| Offer Price | IPO Intelligence Only |
| Price Range | IPO Intelligence Only |
| Offer Shares (mm) | IPO Intelligence Only |
| Deal Size ($mm) | $44 |
| Lock-Up Date | IPO Intelligence Only |
| Street Research | IPO Intelligence Only |
| Underwriters |
|---|
| IPO Intelligence Only |
| Company Data | |
|---|---|
| Headquarters | Aliso Viejo, CA, United States |
| Founded | 1998 |
| Employees at IPO | 94 |
| Website www.SenoRx.com | |
IPO News for SenoRx
SenoRx (SENO) Performance
